patient-centered care

Interview

COA Speaks Out Against PBM Restrictions of Medication Access

10/12/2016

JCP Editors

CVS Caremark®, one of the leading pharmacy benefit managers (PBMs) in the United States, recently made a decision to restrict patient access to physician dispensing of medication directly to patients at their clinic...

CVS...

10/12/2016

Journal of Clinical Pathways

Editor's Page

Accounting for Patient Differences in the Pathway

10/12/2016

Winston Wong, PharmD, Editor-in-Chief

At the first Clinical Pathways Congress (September 16-18; Boston, MA), the official meeting of Journal of Clinical Pathways, one of the themes that came up continuously throughout the meeting was the importance of...

At the...

10/12/2016

Journal of Clinical Pathways

Research in Review

Patient, Policymaker Conceptions of Value in Cancer Care Differ

10/07/2016

JCP Editors

New findings presented by the Cancer Support Community suggest that a significant proportion of patients have difficulty conceptualizing value in terms of current cost-benefit models used by...

New...

10/07/2016

Journal of Clinical Pathways

Pharma Insights

Clarity Regarding Prostate Cancer Screening, Why Payers Need It Too

09/06/2016

Jeremy Schafer, PharmD, MBA

Controversy over the lack of a survival benefit associated with early diagnosis of prostate cancer through prostate-specific antigen (PSA) screening has led to uncertainty in the determination of PSA coverage and its...

...

09/06/2016

Journal of Clinical Pathways

Research in Review

Patient-Reported Quality of Life Predicts Long-Term Lung Cancer Survival

09/06/2016

JCP Editors

Patient-reported quality of life (QOL) may have prognostic value for long-term survival in disease-free survivors of surgically treated lung cancer who have completed active treatment, according to research published...

...

09/06/2016

Journal of Clinical Pathways

Research in Review

Scan-associated Distress Common and Problematic Among Patients With NSCLC

08/25/2016

JCP Editors

Scan-associated distress, a common problem among patients with non-small cell lung cancer (NSCLC), may negatively affect quality of life, according to a study published in the journal Lung Cancer. Commonly referred...

...

08/25/2016

Journal of Clinical Pathways

Research in Review

Systemic Therapy Use Growing Among Elderly Patients With Head and Neck Cancer

08/12/2016

JCP Editors

Despite conflicting prospective evidence, most elderly patients with locoregionally advanced head and neck cancer treated with definitive radiotherapy also receive systemic therapy, according to results from a study...

...

08/12/2016

Journal of Clinical Pathways

Pharma Insights

Could the Lack of an Efficient and Affordable Diagnostic Pathway Limit Market Access for New Alzheimer`s Treatments?

06/20/2016

Rick Lifsitz, MBA

Larry Blandford, PharmD—Column Editor

The promise in the coming years of a novel therapeutic to slow the progression of the debilitating effects of Alzheimer’s disease (AD) is exciting and represents a monumental step forward in treating patients with...

The...

06/20/2016

Journal of Clinical Pathways

Research in Review

Formula for Optimal Radiosurgery Dose Developed to Guide Brain Metastasis Treatment

06/15/2016

JCP Editors

Researchers from the department of radiation oncology at the VU University Medical Center in Amsterdam, the Netherlands, have proposed a novel formula for the optimization of radiosurgery dose for any given lesion...

...

06/15/2016

Journal of Clinical Pathways

Web Application Improves Survival and Follow-up for Patients With Lung Cancer

06/10/2016

JCP Editors

Using a web-based application to guide follow-up for patients with advanced lung cancer after they have received initial therapy may improve survival, according to a study presented at the 2016 American Society of...

Using...

06/10/2016

Journal of Clinical Pathways